FIELD: chemistry.
SUBSTANCE: invention relates to novel agonists β-receptor of thyroid hormones of formula (I) and their use for preventing or treating diseases associated with action of an agonist β-receptor, wherein said disease includes, for example, obesity, hyperlipidemia, hypercholesterolemia, diabetes, liver disease, particularly fatty hepatosis, NASH, NAFLD, cardiovascular diseases, in particular atherosclerosis, thyroid diseases, in particular hypothyroidism or thyroid cancer. $$$ Formula I.
EFFECT: compounds have better activity, selectivity or safety.
16 cl, 2 dwg, 10 tbl, 52 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SUBSTITUTED DIAMINO-CARBOXAMIDE AND DIAMINO-CARBONITRILE PYRIMIDINE DERIVATIVES, THEIR COMPOSITIONS AND METHODS OF TREATMENT USING THEM | 2012 |
|
RU2625309C2 |
| NOVEL CYCLIN-DEPENDENT KINASE CDK9 INHIBITOR | 2018 |
|
RU2738654C1 |
| CALPAIN MODULATORS AND THEIR THERAPEUTIC USE | 2017 |
|
RU2773288C2 |
| MODULATORS OF HEC1 ACTIVITY AND METHODS THEREFOR | 2011 |
|
RU2576036C2 |
| COMPOUND WITH NEUROPROTECTOR ACTION, A METHOD OF ITS PRODUCTION AND ITS USE | 2020 |
|
RU2802457C1 |
| SUBSTITUTED INDOLE COMPOUNDS AS REDUCING REGULATORS OF ESTROGEN RECEPTORS | 2017 |
|
RU2722441C2 |
| SUBSTITUTED HETEROCYCLIC SULPHONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS | 2014 |
|
RU2675792C2 |
| PROTEOLYSIS MODULATORS AND RELATED USES | 2019 |
|
RU2805511C2 |
| THIENODIAZEPINE DERIVATIVES AND THEIR USE | 2018 |
|
RU2795005C2 |
| PYRIMIDINE COMPOUND WITH CONDENSED RINGS, ITS INTERMEDIATE COMPOUND, METHOD OF PRODUCING, COMPOSITION AND USE | 2016 |
|
RU2732576C2 |
